摘要
合并冠状动脉病变的缺血性脑血管病(ICVD)患者在临床上较为常见,无论是否存在心肌缺血症状,其心脑血管事件的发生和复发以及死亡风险均较单纯ICVD者显著增加。目前,对ICVD患者心脑血管联合病变的重视程度不足,传统的分科诊治和研究方式难以满足对该类患者的总体防控需求。同时,国内外尚缺乏针对性的筛查及防治规范,也缺少相应的研究数据。因此,需通过加强多学科合作,增进对ICVD患者心脑血管病变的综合评价,兼顾心、脑两个器官及其供血动脉的情况实施诊治及判断预后,以探索规范化和整体化的心脑血管病变联合评估及防控模式。
Ischemic cerebral vascular disease( ICVD) patients with coronary artery disease are common in clinical practice. Regardless of the presence or absence of the symptoms of myocardial ischemia,the occurrence,recurrence and mortality risk of cardio-cerebrovascular events are significantly higher than those of ICVD alone. At present,the importance of combined cardio-cerebrovascular lesions in patients with ICVD is insufficient,and the traditional diagnosis and treatment according to departments and research modes are difficult to meet the overall needs of prevention and control of such patients. At the same time,there is still a lack of targeted screening and prevention norms at home and abroad and corresponding research data. Therefore,it is necessary to strengthen multidisciplinary cooperation to enhance the comprehensive evaluation of cardio-cerebrovascular diseases in patients with ICVD,and to give consideration to the diagnosis,treatment and prognosis of both heart and brain,and their blood supply arteries,so as to explore a standardized and integrated mode of combined assessment and prevention and control of cardio-cerebrovascular diseases.
引文
[1]TouzéE,Varenne O,Calvet D,et al.Coronary risk stratification in patients with ischemic stroke or transient ischemic stroke attack[J].Int J Stroke,2007,2(3):177-183.
[2]Adams RJ,Chimowitz MI,Alpert JS,et al.Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke:a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association[J].Stroke,2003,34(9):2310-2322.
[3]Amarenco P,Lavallee PC,Labreuche J,et al.Coronary artery disease and risk of major vascular events after cerebral infarction[J].Stroke,2013,44(6):1505-1511.
[4]Yoo J,Song D,Baek JH,et al.Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CT[J].Atherosclerosis,2017,265:7-13.
[5]Prosser J,Macgregor L,Lees KR,et al.Predictors of early cardiac morbidity and mortality after ischemic stroke[J].Stroke,2007,38(8):2295-2302.
[6]Alqahtani F,Aljohani S,Tarabishy A,et al.Incidence and outcomes of myocardial infarction in patients admitted with acute ischemic stroke[J].Stroke,2017,48(11):2931-2938.
[7]Gattringer T,Niederkorn K,Seyfang L,et al.Myocardial infarction as a complication in acute stroke:results from the austrian stroke unit registry[J].Cerebrovasc Dis,2014,37(2):147-152.
[8]Scheitz JF,Nolte CH,Laufs U,et al.Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke[J].Stroke,2015,46(4):1132-1140.
[9]Touze E,Varenne O,Chatellier G,et al.Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke:a systematic review and meta-analysis[J].Stroke,2005,36(12):2748-2755.
[10]Gunnoo T,Hasan N,Khan MS,et al.Quantifying the risk of heart disease following acute ischaemic stroke:a meta-analysis of over 5 0,0 0 0 participants[J].BM J Open,2016,6(1):e9535.
[11]Dhamoon MS,Sciacca RR,Rundek T,et al.Recurrent stroke and cardiac risks after first ischemic stroke:the Northern Manhattan Study[J].Neurology,2006,66(5):641-646.
[12]Towfighi A,Markovic D,Ovbiagele B.Utility of Framingham Coronary Heart Disease Risk Score for predicting cardiac risk after stroke[J].Stroke,2012,43(11):2942-2947.
[13]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心血管病预防指南[J].中华心血管病杂志,2011,39(1):3-22.
[14]Lackland DT,Elkind MS,D'Agostino R Sr,et al.Inclusion of stroke in cardiovascular risk prediction instruments:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2012,43(7):1998-2027.
[15]Lindholm D,Lindbck J,Armstrong PW,et al.Biomarkerbased risk model to predict cardiovascular mortality in patients with stable coronary disease[J].J Am Coll Cardiol,2017,70(7):813-826.
[16]Wrigley P,Khoury J,Eckerle B,et al.Prevalence of positive troponin and echocardiogram findings and association with mortality in acute ischemic stroke[J].Stroke,2017,48(5):1226-1232.
[17]Garcia-Berrocoso T,Giralt D,Bustamante A,et al.B-type natriuretic peptides and mortality after stroke:a systematic review and meta-analysis[J].Neurology,2013,81(23):1976-1985.
[18]Wolk MJ,Bailey SR,Doherty JU,et al.for American College of Cardiology Foundation Appropriate Use Criteria Task Force.ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,American Heart Association,American Society of Echocardiography,American Society of Nuclear Cardiology,Heart Failure Society of America,Heart Rhythm Society,Society for Cardiovascular Angiography and Interventions,Society of Cardiovascular Computed Tomography,Society for Cardiovascular Magnetic Resonance,and Society of Thoracic Surgeons[J].J Am Coll Cardiol,2014,63(4):380-406.
[19]Ovbiagele B,Liebeskind DS,Kim D,et al.Optimizing screening and management of asymptomatic coronary artery disease in patients with stroke and patients with transient ischemic attack[J].Stroke,2009,40(10):3407-3409.
[20]Kim YD,Song D,Nam HS,et al.Increased risk of cardiovascular events in stroke patients who had not undergone evaluation for coronary artery disease[J].Yonsei Med J,2017,58(1):114-122.
[21]Furuang L,Siennicki-Lantz A,Elmstahl S.Reduced cerebral perfusion in elderly men with silent myocardial ischaemia and nocturnal blood pressure dipping[J].Atherosclerosis,2011,214(1):231-236.
[22]Shakur SF,Hrbac T,Alaraj A,et al.Effects of extracranial carotid stenosis on intracranial blood flow[J].Stroke,2014,45(11):3427-3429.
[23]Rothwell PM,Howard SC,Spence JD.Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease[J].Stroke,2003,34(11):2583-2590.
[24]Izzo JJ,Gradman AH.Mechanisms and management of hypertensive heart disease:from left ventricular hypertrophy to heart failure[J].Med Clin North Am,2004,88(5):1257-1271.
[25]Rosendorff C,Lackland DT,Allison M,et al.Treatment of hypertension in patients with coronary artery disease:a scientific statement from the American Heart Association,American College of Cardiology,and American Society of Hypertension[J].J Am Coll Cardiol,2015,65(18):1998-2038.
[26]Valgimigli M,Bueno H,Byrne RA,et al.2017 ESCfocused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS:the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology(ESC)and of the European Association for CardioThoracic Surgery(EACTS)[J].Eur Heart J,2018,39(3):213-260.
[27]Kernan WN,Ovbiagele B,Black HR,et al.Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the A m erican H eart A ssociation/A m erican Stroke A ssociation[J].Stroke,2014,45(7):2160-2236.
[28]Boulanger M,Cameliere L,Felgueiras R,et al.Periprocedural myocardial infarction after carotid endarterectomy and stenting:systematic review and meta-analysis[J].Stroke,2015,46(10):2843-2848.
[29]Illuminati G,Ricco JB,Greco C,et al.Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease:a randomised controlled trial[J].Eur J Vasc Endovasc Surg,2010,39(2):139-145.
[30]Illuminati G,Schneider F,Greco C,et al.Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease[J].Eur J Vasc Endovasc Surg,2015,49(4):366-374.
[31]Vincent S,Eberg M,Eisenberg MJ,et al.Meta-analysis of randomized controlled trials comparing the long-term outcomes of carotid artery stenting versus endarterectomy[J].Circ Cardiovasc Qual Outcomes,2015,8(6 Suppl 3):S99-S108.
[32]Piatek J,Kedziora A,Dzierwa K,et al.Hybrid one-day coronary artery bypass grafting and carotid artery stentingcardiac surgeons'perspective on the procedure's safety[J].Postepy Kardiol Interwencyjnej,2018,14(1):99-102.
[33]Tomai F,Pesarini G,Castriota F,et al.Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses[J].JACC Cardiovasc Interv,2011,4(5):560-568.
[34]Feldman DN,Swaminathan RV,Geleris JD,et al.Comparison of trends and in-hospital outcomes of concurrent carotid artery revascularization and coronary artery bypass graft surgery:the United States experience 2004 to 2012[J].JACC Cardiovasc Interv,2017,10(3):286-298.
[35]Zhao W,Zhang J,Sadowsky MG,et al.Remote ischaemic conditioning for preventing and treating ischaemic stroke[J].Cochrane Database Syst Rev,2018,7:D12503.
[36]Zhou D,Ding J,Ya J,et al.Remote ischemic conditioning:a pr omising therapeutic intervention for multi-organ protection[J].Aging(Albany NY),2018,10(8):1825-1855.
